Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: If each potential infringer has been given a ballpark figure for a license,

"how many would prefer to settle before re-examination is completed?"

According to the current lack of licensees several hundreds of informed companies don't seem to be afraid of the USPTO outcome .

From the Conference Call:

"The decline is attributable primarily to the previously stated reduction in MMP portfolio licensing activity."

I'd really wish, those companies would share my view, that the probability of a positive revalidation is higher than the rejection, but so far I see no signs for this.

Maybe the license prices have NOT gone up as we hoped, so it's still ok for many companies to wait for the USPTO decision?

GLTY

6
Jan 15, 2009 01:35PM
5
Jan 15, 2009 02:49PM
Share
New Message
Please login to post a reply